DIA
BSTC

Denver Investment Advisors’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Denver Investment Advisors’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-4,842
Closed -$211K – 541
2015
Q3 		$211K Sell
4,842
-167
-3% -$9.01K 0.01% 454
2015
Q2 		$258K Sell
5,009
-3,250
-39% -$139K 0.01% 441
2015
Q1 		$323K Buy
+8,259
New +$324K 0.01% 462

Other funds holding BSTC

ACA
Abdiel Capital Advisors New York $52M AUM 13.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RCMC
RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Denver Investment Advisors's BSTC Position: Q4 2015 in Review

Denver Investment Advisors sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2015, closing a stake of 4,842 shares — an estimated $211K sold.

Denver Investment Advisors first reported a position in BSTC in Q1 2015 and held it in 3 quarters. The position peaked at $323K in Q1 2015. 95 funds tracked by Wall St. Rank hold BSTC as of Q4 2015.

  • Denver Investment Advisors reported no remaining BioSpecifics Technologies Corp. position as of Q4 2015 after selling out during the quarter.
  • Denver Investment Advisors sold 4,842 BioSpecifics Technologies Corp. shares in Q4 2015, an estimated $211K.
  • Denver Investment Advisors first reported a position in BioSpecifics Technologies Corp. in Q1 2015 and held it in 3 quarters.
  • Denver Investment Advisors's BioSpecifics Technologies Corp. position peaked at $323K in Q1 2015.
  • 95 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2015.

Based on Denver Investment Advisors's 13F filing for Q4 2015, filed 3 Feb 2016.